Insider Profile
Dunn, Robert
1
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Jun 11, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Jun 11, 2026 $ADK
Diagnos Inc.
Comp. Grant Buy 250,000 $0.20 $50K 73
Sep 28, 2025 $ADK
Diagnos Inc.
Expiry Sell 500,000 73
Sep 25, 2025 $ADK
Diagnos Inc.
Comp. Grant Buy 500,000 $0.26 $130K 73
Sep 05, 2025 $ADK
Diagnos Inc.
Open Market Sell 73
Sep 05, 2025 $ADK
Diagnos Inc.
Comp. Grant Buy 100,000 73
Aug 31, 2025 $ADK
Diagnos Inc.
Other Sell 73
Oct 03, 2024 $ADK
Diagnos Inc.
Comp. Grant Buy 150,000 $0.37 $56K 73
Feb 29, 2024 $ADK
Diagnos Inc.
Expiry Sell 100,000 $0.26 $26K 73
Feb 10, 2023 $ADK
Diagnos Inc.
Comp. Grant Buy 150,000 $0.42 $64K 73
Feb 27, 2021 $ADK
Diagnos Inc.
Exercise Sell 250,000 $0.25 $62K 73
Feb 26, 2021 $ADK
Diagnos Inc.
Exercise Buy 250,000 $0.25 $62K 73
Oct 01, 2020 $ADK
Diagnos Inc.
Open Market Buy 398,000 $0.28 $109K 73
Sep 30, 2020 $ADK
Diagnos Inc.
Open Market Buy 602,000 $0.27 $163K 73
Sep 28, 2020 $ADK
Diagnos Inc.
Comp. Grant Buy 500,000 $0.28 $142K 73
Sep 28, 2020 $ADK
Diagnos Inc.
Other Sell 73
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.